Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Technetium-99m (99mTc) is a radioactive substance that is used in nuclear medicine departments worldwide. This substance when made in an appropriate formulation is injected in patients and following its decay pictures of the patient can be obtained. This pictures help physicians diagnose certain diseases notably cancers and heart diseases. The government of Canada historically was the main producer of this radioactive substance. Due to the aging of the machines that are used to produce these substance the government announced that in 2019 it will no longer be producing Tc-99m. To fill this looming gap Canadian Isotope Innovations Corp (CIIC) has developed a new technology to produce this much needed isotope. However, before this isotope can become available to patients it needs to be processed. The new technology used by CIIC involves the use of an expensive starting material called enriched molybdenum (Mo-100). TO BE CONT’D
Humphrey Fonge
Saeed Shanehsazzadeh
Canadian Isotope Innovations
Medicine
Medical devices
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.